TY - JOUR
T1 - Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
AU - Yamaguchi, Noritaka
AU - Ito, Taku
AU - Azuma, Sakura
AU - Ito, Emi
AU - Honma, Reiko
AU - Yanagisawa, Yuka
AU - Nishikawa, Akira
AU - Kawamura, Mika
AU - Imai, Jun ichi
AU - Watanabe, Shinya
AU - Semba, Kentaro
AU - Inoue, Jun ichiro
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2009/9
Y1 - 2009/9
N2 - Constitutive nuclear factor (NF)-κB activation is thought to be involved in survival, invasion, and metastasis in various types of cancers.However, neither the subtypes of breast cancer cells with constitutive NF-κB activation nor the molecular mechanisms leading to its constitutive activation have been clearly defined. Here, we quantitatively analyzed basal NF-κB activity in 35 human breast cancer cell lines and found that most of the cell lines with high constitutive NF-κB activation were categorized in the estrogen receptor negative, progesterone receptor negative, ERBB2 negative basal-like subtype, which is the most malignant form of breast cancer. Inhibition of constitutive NF-κB activation by expression of IκBα super-repressor reduced proliferation of the basal-like subtype cell lines. Expression levels of mRNA encoding NF-κB-inducing kinase (NIK) were elevated in several breast cancer cell lines, and RNA interference-mediated knockdown of NIK reduced NF-kB activation in a subset of the basal-like subtype cell lines with upregulated NIK expression. Taken together, these results suggest that constitutive NF-κB activation, partially dependent on NIK, is preferentially involved in proliferation of basal-like subtype breast cancer cells and may be a useful therapeutic target for this subtype of cancer.
AB - Constitutive nuclear factor (NF)-κB activation is thought to be involved in survival, invasion, and metastasis in various types of cancers.However, neither the subtypes of breast cancer cells with constitutive NF-κB activation nor the molecular mechanisms leading to its constitutive activation have been clearly defined. Here, we quantitatively analyzed basal NF-κB activity in 35 human breast cancer cell lines and found that most of the cell lines with high constitutive NF-κB activation were categorized in the estrogen receptor negative, progesterone receptor negative, ERBB2 negative basal-like subtype, which is the most malignant form of breast cancer. Inhibition of constitutive NF-κB activation by expression of IκBα super-repressor reduced proliferation of the basal-like subtype cell lines. Expression levels of mRNA encoding NF-κB-inducing kinase (NIK) were elevated in several breast cancer cell lines, and RNA interference-mediated knockdown of NIK reduced NF-kB activation in a subset of the basal-like subtype cell lines with upregulated NIK expression. Taken together, these results suggest that constitutive NF-κB activation, partially dependent on NIK, is preferentially involved in proliferation of basal-like subtype breast cancer cells and may be a useful therapeutic target for this subtype of cancer.
UR - http://www.scopus.com/inward/record.url?scp=70149106789&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70149106789&partnerID=8YFLogxK
U2 - 10.1111/j.1349-7006.2009.01228.x
DO - 10.1111/j.1349-7006.2009.01228.x
M3 - Article
C2 - 19538528
AN - SCOPUS:70149106789
SN - 1347-9032
VL - 100
SP - 1668
EP - 1674
JO - Cancer Science
JF - Cancer Science
IS - 9
ER -